Document is current
Any future updates will be listed below
-
Authors
Morad, Golnaz https://orcid.org/0000-0002-9460-618X
Damania, Ashish V.
Melendez, Brenda https://orcid.org/0000-0001-8789-6791
Singh, Bharat B.
Veguilla, Fabiana J.
Soto, Rebecca A.
Hoballah, Yasmine M.
Sahasrabhojane, Pranoti V.
Wong, Matthew C.
Ahmed, Mona M.
Rico, Rene N.
Lewis, Kaitlyn N.
Wani, Khalida
Shamsutdinova, Diana D.
Lazcano Segura, Rossana N.
Ingram, Davis R.
Goethe, Eric A.
Day, Abderrahman
Flores, Ivonne I.
McDaniel, Lauren K.
Chelvanambi, Manoj https://orcid.org/0000-0003-2130-3118
Johnson, Sarah B.
Dimitriou, Florentia
Gupta, Pravesh https://orcid.org/0000-0002-1643-8950
Oberai, Shivangi
Zal, M. Anna https://orcid.org/0000-0002-1015-3954
Doss, Phoebe
Jamal, Mohamed A.
Hayase, Eiko
Wathoo, Chetna
Norberg, Lisa M.
Jenkins, Stephanie L. https://orcid.org/0009-0004-9194-0205
Nass, Sara
Gumin, Joy
Long, Lihong
Yang, Jing
Bradley, Gina R.
Bekal, Mahesh Prasad https://orcid.org/0000-0002-6329-0477
Dono, Antonio G.
Pichardo-Rojas, Pavel S.
Andrewes, Samuel W.
Ballester, Leomar Y.
Losh, Jillian S. https://orcid.org/0000-0003-4648-6512
Liang, Jiyong
Huo, Longfei
Nielsen, Douglas C.
Parker Kerrigan, Brittany C.
Brastianos, Priscilla K. https://orcid.org/0000-0003-4470-8425
Fowlkes, Natalie Wall https://orcid.org/0000-0002-7711-6031
Chang, Chia-Chi
Jenq, Robert R.
Gomez-Manzano, Candelaria https://orcid.org/0000-0002-1259-2133
Huse, Jason T.
Davies, Michael A. https://orcid.org/0000-0002-0977-0912
Lazar, Alexander J. https://orcid.org/0000-0002-6395-4499
Bhat, Krishna P. https://orcid.org/0000-0002-2020-8509
Tandon, Nitin https://orcid.org/0000-0002-2752-2365
Esquenazi, Yoshua
Peterson, Christine B. https://orcid.org/0000-0003-3316-0468
Puduvalli, Vinay K.
Lang, Frederick F. https://orcid.org/0000-0003-3747-873X
Johnston, Christopher D.
Bullman, Susan https://orcid.org/0000-0002-7713-0810
Ajami, Nadim J. https://orcid.org/0000-0002-3808-8576
Ferguson, Sherise D.
Wargo, Jennifer A. https://orcid.org/0000-0003-3438-7576
- License Information
-
More Information
Article History
Received: 2 January 2025
Accepted: 12 August 2025
First Online: 14 November 2025
Competing interests
: R.R.J. serves as a consultant and provides expert testimony for MaaT Pharma and Postbiotics Plus and receives patent license fees from Seres Therapeutics and stock options from Seres Therapeutics and Postbiotics Plus. Unrelated to this work, P.K.B. has received consultant fees from Atavistik, Advise Connect Inspire, AngioChem, Axiom Healthcare Strategies, CraniUS, Dantari, ElevateBio, Eli Lilly, Genentech, InCephalo Therapeutics, Kazia, Merck, MPM Capital, Pfizer, Sintetica, SK Life Science, Tesaro and Voyager Therapeutics; equity from Selectin Therapeutics; speaker honoraria from Eli Lilly, Genentech, Medscape and Merck; and institutional research funding (to Massachusetts General Hospital) from Eli Lilly, Kinnate Biopharma, Merck and Mirati. M.A.D. has been a consultant to Roche/Genentech, Array, Pfizer, Novartis, Bristol Myers Squibb, GlaxoSmithKline, Sanofi-Aventis, Vaccinex, Apexigen, Eisai, Iovance, Merck and ABM Therapeutics, and he has been the principal investigator of research grants to MD Anderson by Roche/Genentech, GlaxoSmithKline, Sanofi-Aventis, Merck, Myriad, Oncothyreon, Pfizer, ABM Therapeutics and LEAD Pharma. N.T. is founder and holder of equity in BrainDynamics, Inc. and also holds an equity position in Nervonik. V.K.P. served as an advisory board member and received honoraria from Orbus Therapeutics, Insightec, Novocure, Boehringer Ingelheim, Telix Pharma, Tango Pharmaceuticals, Bayer and Servier; received research support from Bexion, Karyopharm, Remedy Plan Therapeutics, Radiomedix, Merck and Servier; and holds equity in Gilead. J.A.W. reports compensation for speaker’s bureau and honoraria from PeerView and serves as a consultant and/or advisory board member for Gustave Roussy Cancer Center, OSE Immunotherapeutics, Bayer Therapeutics, James Cancer Center OSU and Daiichi Sankyo. The remaining authors declare no competing interests.
